UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer

Breast cancer research and treatment, 2015-04, Vol.150 (2), p.389-394

2015

Volltextzugriff (PDF)

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress

Clinical genetics, 2013-11, Vol.84 (5), p.464-472

2013

Volltextzugriff (PDF)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru

Clinical genetics, 2015-10, Vol.88 (4), p.371-375

2015

Volltextzugriff (PDF)

Folate depletion impairs DNA excision repair in the colon of the rat

Gut, 1998-07, Vol.43 (1), p.93-99

1998

Volltextzugriff (PDF)

Clinical and functional properties of novel VHL mutation (X214L) consistent with Type 2A phenotype and low risk of renal cell carcinoma

Clinical genetics, 2011-06, Vol.79 (6), p.539-545

2011

Volltextzugriff (PDF)

Effects of a cancer genetics education programme on clinician knowledge and practice

Journal of medical genetics, 2004-07, Vol.41 (7), p.518-522

2004

Volltextzugriff (PDF)

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

Oncogene, 2012-10, Vol.31 (42), p.4559-4566

2012

Volltextzugriff (PDF)

Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment

Journal of medical genetics, 2002-07, Vol.39 (7), p.526-530

2002

Volltextzugriff (PDF)

Loss of five amino acids in BRCA2 is associated with ovarian cancer

Journal of medical genetics, 2004-02, Vol.41 (2), p.e18-18

2004

Volltextzugriff (PDF)

Genetic discrimination: the clinician perspective

Clinical genetics, 2004-10, Vol.66 (4), p.311-317

2004

Volltextzugriff (PDF)

The Founder Mutation MSH21906G→C Is an Important Cause of Hereditary Nonpolyposis Colorectal Cancer in the Ashkenazi Jewish Population

American journal of human genetics, 2002-12, Vol.71 (6), p.1395-1412

2002

Volltextzugriff (PDF)

The Power of Genetics to Target Surgical Prevention

The New England journal of medicine, 2001-06, Vol.344 (25), p.1942-1944

2001

Volltextzugriff (PDF)

The HRAS1 minisatellite locus and risk of ovarian cancer

Cancer research (Chicago, Ill.), 2000-01, Vol.60 (2), p.259-261

2000

Volltextzugriff (PDF)

Breast-Cancer Risk in Families with Mutations in PALB2

The New England journal of medicine, 2014-08, Vol.371 (6), p.497-506

2014

Volltextzugriff (PDF)

The crystal ball of genetic cancer risk assessment: who wouldn't want to know their future?

Annals of surgical oncology, 1998-10, Vol.5 (7), p.567-568

Weitzel, J N

1998

Volltextzugriff (PDF)

A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas

Cancer research (Chicago, Ill.), 1997-02, Vol.57 (3), p.387-390

1997

Volltextzugriff (PDF)

Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce

Genetics in medicine, 2011-09, Vol.13 (9), p.832-840

2011

Volltextzugriff (PDF)

Molecular Genetic Changes Associated with Ovarian Cancer

Gynecologic oncology, 1994-11, Vol.55 (2), p.245-252

1994

Volltextzugriff (PDF)

Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene

Oncogene, 1995-07, Vol.11 (2), p.359-363

1995

Volltextzugriff (PDF)

Re: Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

The Journal of urology, 2020-09, Vol.204 (3), p.619-620

Taneja, Samir S.

2020

Volltextzugriff (PDF)

Genetic cancer risk assessment : Putting it all together

Cancer, 1999-10, Vol.86 (8), p.1663-1672

WEITZEL, J. N

1999

Volltextzugriff (PDF)

Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment

Genetics in medicine, 2007-05, Vol.9 (5), p.275-282

2007

Volltextzugriff (PDF)

Abstract MS3-2: Advances in Breast Cancer Risk Assessment, Screening and Prevention: Adapting the Lessons to an Underserved Latina Population

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.MS3-2-MS3-2

Weitzel, JN

2010

Volltextzugriff (PDF)

Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians

Genetics in medicine, 2008-09, Vol.10 (9), p.691-698

2008

Volltextzugriff (PDF)

Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families

Cancer epidemiology, biomarkers & prevention, 2005-07, Vol.14 (7), p.1666-1671

2005

Volltextzugriff (PDF)

1 – 25 von 263

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(240)
Mit Volltextzugriff
(230)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru

Folate depletion impairs DNA excision repair in the colon of the rat

Clinical and functional properties of novel VHL mutation (X214L) consistent with Type 2A phenotype and low risk of renal cell carcinoma

Effects of a cancer genetics education programme on clinician knowledge and practice

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment

Loss of five amino acids in BRCA2 is associated with ovarian cancer

Genetic discrimination: the clinician perspective

The Founder Mutation MSH21906G→C Is an Important Cause of Hereditary Nonpolyposis Colorectal Cancer in the Ashkenazi Jewish Population

The Power of Genetics to Target Surgical Prevention

The HRAS1 minisatellite locus and risk of ovarian cancer

Breast-Cancer Risk in Families with Mutations in PALB2

The crystal ball of genetic cancer risk assessment: who wouldn't want to know their future?

A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas

Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce

Molecular Genetic Changes Associated with Ovarian Cancer

Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene

Re: Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Genetic cancer risk assessment : Putting it all together

Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment

Abstract MS3-2: Advances in Breast Cancer Risk Assessment, Screening and Prevention: Adapting the Lessons to an Underserved Latina Population

Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians

Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families

Suchergebnisse filtern